P06401 (PRGR_HUMAN) Homo sapiens (Human)

Progesterone receptor UniProtKBInterProSTRINGInteractive Modelling

933 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4; Isoform 5)

Available Structures

20 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Progesterone receptor with bound ulipristal acetate and a peptide from the co-repressor SMRT Heteromer
Q9Y618;
682-931
2S0;
Assess
Progesterone Receptor Hormone Binding Domain with Bound Mometasone Furoatehomo-2-mer682-932
MOF;SO4;GOL;
Assess
Progesterone Receptor with bound Pyrrolidine 1homo-2-mer682-932
30X;SO4;
Assess
Progesterone receptor ligand binding domain in complex with the nonsteroidal agonist tanaprogethomo-2-mer682-932
T98;SO4;
Assess
Progesterone Receptor bound to an Alkylpyrrolidine ligand.homo-2-mer682-932
SO4;GKK;GOL;
Assess
STRUCTURE OF THE PROGESTERONE RECEPTOR-DNA COMPLEXhomo-2-mer563-640
ZN;
Assess
AncSR2 - TSLP nGRE complexhomo-2-mer564-636
ZN;
Assess
Progesterone receptor bound to sulfonamide pyrrolidine partial agonistmonomer682-933
WOW;SO4;
Assess
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor SMRTmonomer681-932
AS0;
Assess
Progesterone Receptor Ligand Binding Domain with bound Norethindronemonomer682-932
NDR;
Assess
HORMONE-BOUND HUMAN PROGESTERONE RECEPTOR LIGAND-BINDING DOMAINmonomer682-932
STR;
Assess
RU486 bound to the progesterone receptor in a destabilized agonistic conformationmonomer683-933
486;SO4;
Assess
Progesterone Receptor with Bound Asoprisnil and a Peptide from the Co-Repressor NCoRmonomer682-932
AS0;
Assess
Human Progesteron Receptor Ligand Binding Domain in complex with the ligand metribolone (R1881)monomer682-932
R18;
Assess
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor m…monomer683-932
OR8;GOL;SO4;
Assess
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor m…monomer683-932
OR8;SO4;GOL;
Assess
PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in…monomer683-932
OR8;SO4;
Assess
Structural basis for agonism and antagonism for a set of chemically related progesterone receptor m…monomer683-932
ORB;SO4;
Assess
PR X-Ray structures in agonist conformations reveal two different mechanisms for partial agonism in…monomer683-932
AS0;SO4;
Assess
Crystal structure of the human progesterone receptor ligand-binding domain bound to levonorgestrelmonomer682-931
NOG;
Assess

5 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
3g8n.1.Ahomo-2-mer0.81682-932
GKK;100.00
Assess
7prw.1.Amonomer0.74561-933
ZN;56.44
Assess
7prw.1.Bmonomer0.73564-933
ZN;56.44
Assess
7kw7.1.Fmonomer0.68668-933
57.02
Assess
3dzu.1.Bmonomer0.55564-915
ZN;21.74
Assess

12 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 27prw.1.Amonomer0.74397-769
ZN;56.87
Assess
Isoform 27prw.1.Bmonomer0.73400-769
ZN;56.87
Assess
Isoform 27kw7.1.Fmonomer0.70510-769
57.18
Assess
Isoform 23dzu.1.Bmonomer0.55400-751
ZN;22.03
Assess
Isoform 31sr7.1.Ahomo-2-mer0.8688-338
MOF;100.00
Assess
Isoform 37prw.1.Amonomer0.721-339
ZN;55.32
Assess
Isoform 37prw.1.Bmonomer0.711-339
ZN;55.32
Assess
Isoform 43g8o.1.Ahomo-2-mer0.8963-313
30X;100.00
Assess
Isoform 47kw7.1.Fmonomer0.7162-314
52.21
Assess
Isoform 57prw.1.Bmonomer0.76564-831
63.47
Assess
Isoform 57prw.1.Amonomer0.75561-831
ZN;63.47
Assess
Isoform 51qkt.1.Bmonomer0.63626-817
22.46
Assess